Organized Prostate Cancer Testing in Sweden Significantly Reduces Advanced Cancer Risks

Since its nationwide implementation in 2020, Organized Prostate Cancer Testing (OPT) has made substantial progress in Sweden's efforts to reduce advanced prostate cancer cases. The program invites men aged 50 and older for regular PSA testing, with intervals adjusted based on previous results. To minimize overdiagnosis—where non-threatening tumors might lead to unnecessary treatment—magnetic resonance imaging (MRI) is used as an intermediate step before biopsy recommendations.

According to Ola Bratt, chairman of the national working group for OPT, participation in this structured testing notably decreases the risk of advanced prostate cancer. More than 300,000 men, primarily aged 50 to 56, have been offered testing, and nearly half have opted in. Public health reports reveal that among over 20,000 men who underwent repeated testing, only six developed locally advanced or metastatic cancer, while 208 cases were identified as likely curable.

OPT addresses prior challenges associated with unorganized PSA testing, which failed to significantly reduce mortality and resulted in resource waste and inequalities due to uneven awareness and access. The program ensures equitable testing regardless of socioeconomic background or geographic location. As Bratt emphasizes, waiting for symptoms often means detection at an advanced stage, underlining the importance of this early detection initiative. Since 2025, all but two regions, Blekinge and Halland, have adopted OPT, marking a near nationwide effort in proactive prostate cancer screening.